Epigallocatechingallate sensitizes cervical cancer cells to cisplatin via Nrf2/HO-1 and m-Tor signaling pathway

---

ŞAHİN K., TUZCU M., BAŞAK TÜRKMEN N., orhan c., ÇAĞLAYAN A. B., AĞCA C. A., ...More

5th International Congress on Nutrition and Cancer, 09 September 2012, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Inonu University Affiliated: Yes